The Unseen Financial and Human Toll of Clinical Trial Imaging Errors
The clinical trial landscape faces significant challenges impacting financial outcomes and patient well-being, with clinical trial imaging errors being...
Moe Alsumidaie
Roche Innovative Approach to Digital Biomarkers in Alzheimer’s Disease Research
The Panagora 7th Annual Digital Biomarkers in Clinical Trials Summit, held in Basel, Switzerland, was a hub of innovation,...
Novartis Makes Advancements in Digital Biomarkers for Knee Osteoarthritis
The 7th Annual Digital Biomarkers in Clinical Trials Summit recently featured a compelling presentation by William Johnston, Digital Endpoint...
Innovative AI in Trials: Reducing Costs and Enhancing Privacy
In this insightful interview, I spoke with Gen Li, CEO of Phesi, a pioneering company focusing on AI in...
What Does The Future Hold for RBQM in Clinical Trials?
In this interview, I speak with Duncan Hall, CEO of Tritrials, about the importance of Risk-Based Quality Management (RBQM)...
Advancing Drug Development: FDA’s Take on In Silico Trials
The Clinical Trial Transformation Initiative (CTTI) and the FDA hosted a workshop on Artificial Intelligence in Drug & Biological...
Unlocking Digital Endpoints: A New Era in Trials
In the rapidly evolving world of clinical trials, digital endpoints are emerging as critical components that enhance the precision...
Navigating the Complexities of Cell and Gene Therapy Manufacturing
The 2024 DIA conference, a session about gene therapy manufacturing chaired by Dr. Fouad Atouf, Senior Vice President of...
AI and ML in Predicting Biopharmaceutical Product Profile Approvability
In a fascinating session, “Applying Machine Learning and Artificial Intelligence for Predicting Product Profile Approvability” session, industry leaders dissected...
Surge in Septic Shock Care: Vivacelle’s Innovative Approach
We had the chance to sit down with Harven DeShield, Chief Executive Officer and Co-founder of Vivacelle Bio. We...